Exponent to Announce First Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on April 25, 2024

Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2024 financial results for the period ended March 29, 2024 following the close of the market on Thursday, April 25, 2024. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.

Event:	Exponent, Inc. First Quarter of Fiscal Year 2024 Financial Results
	Conference Call
Date:	Thursday, April 25, 2024
Time:	4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time
Live Call:	[phone] or [phone]

Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www.exponent.com/investors. A telephonic replay of the conference call will be available until Thursday, May 2, 2024 by dialing [phone] or [phone] and entering passcode 9671556#. 

About ExponentExponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward. 

Exponent may be reached at (888) 656-EXPO, [e-mail], or www.exponent.com.